Home » ANTARES TO LAUNCH ANUTROL TRIAL
ANTARES TO LAUNCH ANUTROL TRIAL
Antares Pharma is getting ready to initiate a Phase-III clinical trial for Anutrol, an experimental treatment for overactive bladder.
Anturol is a clear and odorless gel formulation of oxybutynin that is designed to be absorbed through the skin following a once-a-day application to the abdomen. The formulation uses Antares' proprietary advanced transdermal delivery platform.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May